AFMD - Affimed N.V. - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-57.42M

Cash

120.1M

Avg Qtr Burn

-29.14M

Short % of Float

1.29%

Insider Ownership

4.71%

Institutional Own.

54.26%

Qtr Updated

06/30/23

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
AFM13 (Acimtamig)+ cbNK cells Details Cancer, Non-Hodgkin lymphoma	Phase 2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AFM13 (Acimtamig) Details Peripheral T cell cancer , Cancer	Phase 2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AFM24 (tumor target EGFR) w/ SNK01 & atezolizumab Details Solid tumor/s, Cancer	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AFM13 (Acimtamig) + AB-101 Details Cancer, Lymphoma, Hodgkin Lymphoma, peripheral T-cell lymphomas	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AFM28 Details Cancer, Blood cancer, Leukemia, Acute myeloid leukemia	Phase 1 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AFM24 (tumor target EGFR) Monotherapy Details Solid tumor/s, Cancer, Non-small cell lung carcinoma, Colorectal cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
RO7297089 (formerly AFM26) Details Multiple myeloma, Cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.